Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells

Oncogene. 2013 Sep 19;32(38):4572-8. doi: 10.1038/onc.2012.470. Epub 2012 Oct 29.

Abstract

The serum- and glucocorticoid-regulated kinase (Sgk1) is essential for hormonal regulation of epithelial sodium channel-mediated sodium transport and is involved in the transduction of growth factor-dependent cell survival and proliferation signals. Growing evidence now points to Sgk1 as a key element in the development and/or progression of human cancer. To gain insight into the mechanisms through which Sgk1 regulates cell proliferation, we adopted a proteomic approach to identify up- or downregulated proteins after Sgk1-specific RNA silencing. Among several proteins, the abundance of which was found to be up- or downregulated upon Sgk1 silencing, we focused our attention of RAN-binding protein 1 (RANBP1), a major effector of the GTPase RAN. We report that Sgk1-dependent regulation of RANBP1 has functional consequences on both mitotic microtubule activity and taxol sensitivity of cancer cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects
  • Apoptosis / genetics
  • Carcinoma / genetics*
  • Carcinoma / metabolism*
  • Cell Line, Tumor
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / metabolism*
  • Drug Resistance, Neoplasm / genetics*
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Immediate-Early Proteins / metabolism*
  • Nuclear Proteins / genetics*
  • Paclitaxel / pharmacology
  • Phosphorylation
  • Protein Serine-Threonine Kinases / metabolism*
  • Proteomics
  • RNA Interference
  • Sp1 Transcription Factor / metabolism
  • Transcription, Genetic*

Substances

  • Immediate-Early Proteins
  • Nuclear Proteins
  • Sp1 Transcription Factor
  • ran-binding protein 1
  • Protein Serine-Threonine Kinases
  • serum-glucocorticoid regulated kinase
  • Paclitaxel